Understanding genetic determinants of resistance to immune checkpoint blockers

Sandrine Aspeslagh1, Roman M Chabanon2, Stéphane Champiat3

  • 1Department of Medical Oncology, UZ Brussel- VUB, Laarbeeklaan 101, 1090, Jette, Belgium; Department of Medical Oncology and Dermatology, HôPital Erasme - ULB, Route De Lennik 880, 1070, Anderlecht, Brussels, Belgium.

Seminars in Cancer Biology
|December 28, 2019
PubMed

Related Concept Videos